Rating History for Cytokinetics (CYTK) by Goldman Sachs

More Stocks Rated by Goldman Sachs | Latest Ratings for CYTK
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/18/2025 Paul Choi Upgrade Buy
(Neutral)		 95.00
(N/A)		 59.82
(60.41)		 0.99% Details